by Bhavani Srinivasan | Jun 28, 2022 | Newsletters
Our June newsletter is dedicated to the window of opportunity offered by the ongoing revision of the EU’s pharmaceutical legislation to improve access to effective and affordable medicines for everyone. Contrary to what the pharmaceutical industry claims, high prices...
by Bhavani Srinivasan | May 12, 2022
European Alliance for Responsible R&D and Affordable Medicines The Alliance strives for the creation of an R&D system that is driven by public health needs and delivers medicines that are universally accessible and affordable. The Alliance is a free-to-join...
by European Public Health Alliance | May 10, 2022 | Statements
The European Public Health Alliance (EPHA), the European Public Health Association (EUPHA), the Association of Schools of Public Health in the European Region (ASPHER), and the World Federation of Public Health Associations (WFPHA), the leading European and...
by European Public Health Alliance | Apr 22, 2022 | Consultation Responses
WHO has been seeking public input to support the work of the Intergovernmental Negotiating Body (INB) in drafting and negotiating an international instrument to strengthen pandemic prevention, preparedness and response. In their first round of public hearings on 12-13...
by European Public Health Alliance | Apr 20, 2022 | Opinion
The European Parliament is undertaking an extremely important task of examining how the European Union has dealt with the response to the ongoing COVID-19 pandemic. We know that its impact on almost every aspect of our lives and livelihoods has been and often...
